First Capital Advisors Group’s Boston Scientific BSX Stock Holding History

First Capital Advisors Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$296K	Hold	5,473	–	–	0.15%	108
2023 Q1	$274K	Buy	5,473 +12	+0.2%	+$566	0.18%	114
2022 Q4	$253K	Buy	5,461 +4	+0.1%	+$173	0.17%	120
2022 Q3	$211K	Sell	5,457 -192	-3%	-$7.7K	0.18%	131
2022 Q2	$211K	Buy	+5,649	New	+$230K	0.14%	150
2018 Q2	–	Sell	-20	Closed	-$1K	–	250
2018 Q1	$1K	Buy	+20	New	+$544	﹤0.01%	774

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

First Capital Advisors Group's BSX Position: Q2 2023 in Review

First Capital Advisors Group held its Boston Scientific (BSX) position steady in Q2 2023 at 5,473 shares worth $296K. The position accounts for 0.15% of the portfolio, ranked #108.

First Capital Advisors Group first reported a position in BSX in Q1 2018 and has held it in 6 quarters since. 1,066 funds tracked by Wall St. Rank hold BSX as of Q2 2023.

First Capital Advisors Group held 5,473 shares of Boston Scientific worth $296K as of Q2 2023.
First Capital Advisors Group left its Boston Scientific share count unchanged in Q2 2023.
Boston Scientific made up 0.15% of First Capital Advisors Group's portfolio in Q2 2023, its #108 holding.
First Capital Advisors Group first reported a position in Boston Scientific in Q1 2018 and has held it in 6 quarters since.
1,066 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2023.

Based on First Capital Advisors Group's 13F filing for Q2 2023, filed 15 Aug 2023.